Unknown NA INTERVENTIONAL 2-arm NCT02032082

Rule of Carbone Monoxyde in the Ex Vivo Lung Perfusion Reconditionning

Sponsor: University Hospital of Mont-Godinne

Updated 6 times since 2017 Last updated: Mar 13, 2016 Started: Jan 31, 2014 Primary completion: Jan 31, 2018 Completion: Jan 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02032082, this NA trial focuses on Neurogenic Lung Edema and remains ongoing. Sponsored by University Hospital of Mont-Godinne, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Apr 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital of Mont-Godinne

Data source: University Hospital of Mont-Godinne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yvoir, Belgium